Evidence map›Paper›PMID 27367470›Full record

ArticleJAMA psychiatry2016

Schrödinger's Cat and d-Cycloserine to Augment Exposure Therapy-Both Are Alive and Dead.

Stefan G Hofmann

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in JAMA psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Stefan G HofmannDepartment of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.

Funding

Toward Outcome Measurement of Anxiety in Youth with Autism Spectrum DisordersR01MH099021 · NIMH · YALE UNIVERSITY · PI SCAHILL, LAWRENCE D. · 2012 to 2015
$2.7M
1/2-Yoga For Generalized Anxiety DisorderR01AT007257 · NCCIH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2013 to 2017
$2.0M
2/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety DisorderR34MH099311 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI HOFMANN, STEFAN G. · 2014 to 2016
$737k
Exposure Therapy for Fear of Falling in Older AdultsR34MH086668 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WETHERELL, JULIE L · 2010 to 2012
$691k
Fear extinction memory in primary insomniaR21MH101567 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PACE-SCHOTT, EDWARD F. · 2014 to 2015
$464k
Improving Therapeutic Learning in Depression: Proof of ConceptR21MH102646 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI OTTO, MICHAEL W. · 2014 to 2015
$452k
NCCIH NIH HHS R01 AT007257NIMH NIH HHS R01 MH099021NIMH NIH HHS R21 MH101567NIMH NIH HHS R21 MH102646NIMH NIH HHS R34 MH086668NIMH NIH HHS R34 MH099311
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CycloserineImplosive TherapyHumansCycloserine

Identifiers

PMID27367470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.